Sjögren's Syndrome Accompanied by Prolactinoma: a case report and literature review
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Rheumatic Diseases"
DOI: 10.1111/1756-185x.12731
Abstract: Dear Editor, Sj€ ogren’s syndrome (SS) is an autoimmune disease characterized by dryness of the eyes and mouth, which is because of the destruction of salivary and lacrimal glands by infiltrating lymphocytes. Patients with SS… read more here.
Keywords: prolactin; treatment; disease; prolactinoma ... See more keywords
Myasthenia gravis presenting as bilateral pseudointernuclear ophthalmoplegia in a patient with an incidental prolactinoma
Sign Up to like & getrecommendations! Published in 2020 at "BMJ Case Reports"
DOI: 10.1136/bcr-2020-234322
Abstract: Myasthenia gravis (MG) is a rare and potentially dangerous autoimmune condition, which affects the acetylcholine receptors at the neuromuscular junction of skeletal muscle. MG’s diverse symptomatology may readily masquerade as other neurological conditions, posing a… read more here.
Keywords: pseudointernuclear ophthalmoplegia; gravis presenting; prolactinoma; myasthenia gravis ... See more keywords
The side effects of dopamine receptor agonist drugs in Chinese prolactinoma patients: a cross sectional study
Sign Up to like & getrecommendations! Published in 2022 at "BMC Endocrine Disorders"
DOI: 10.1186/s12902-022-01009-3
Abstract: Background Recently, side effects from Dopamine Receptor Agonist Drugs (DAs) in treating pituitary prolactinoma have raised widespread concern. This study explores the incidence and influencing factors of DAs-related side effects in Chinese prolactinoma patients. Methods… read more here.
Keywords: side effects; chinese prolactinoma; prolactinoma; study ... See more keywords
Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Medical Case Reports"
DOI: 10.1186/s13256-018-1939-x
Abstract: BackgroundDopamine agonists are the standard first-line medical therapy for prolactinoma. We report a rare case of giant prolactinoma with a first epileptic seizure due to rapid reduction of the tumor as a complication of dopamine… read more here.
Keywords: agonist therapy; case; prolactinoma; therapy ... See more keywords
ODP334 Must we Wait for the Development of Metastasis to be Able to Distinguish Dopamine Resistant Aggressive Prolactinoma from Prolactin Producing Pituitary Carcinomas? Case Report and Literature Review
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvac150.1043
Abstract: Abstract Background Prolactinomas, the most prevalent type of neuroendocrine disease, account for approximately 40% of all pituitary adenomas. In the vast majority of cases, these are benign tumors with excellent clinical response to medical therapy… read more here.
Keywords: prolactinoma; development metastasis; dopamine; case ... See more keywords
Case Report of a Prolactinoma in a Patient With a Novel MAX Mutation and Bilateral Pheochromocytomas
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the Endocrine Society"
DOI: 10.1210/js.2017-00135
Abstract: Pheochromocytomas are neuroendocrine tumors that can arise sporadically or be inherited as a familial disease, and they may occur in isolation or as part of a multitumor syndrome. Familial disease typically presents in younger patients… read more here.
Keywords: max; prolactinoma; max mutation; bilateral pheochromocytomas ... See more keywords
ALK7 expression in prolactinoma is associated with reduced prolactin and increased proliferation.
Sign Up to like & getrecommendations! Published in 2018 at "Endocrine-related cancer"
DOI: 10.1530/erc-18-0082
Abstract: Prolactinoma represents the most frequent hormone-secreting pituitary tumours. These tumours appear in a benign form, but some of them can reach an invasive and aggressive stage through an unknown mechanism. Discovering markers to identify prolactinoma… read more here.
Keywords: prolactin; alk7 expression; prolactinoma; expression ... See more keywords
TLR4 inhibition suppresses growth in oestrogen-induced prolactinoma models.
Sign Up to like & getrecommendations! Published in 2022 at "Endocrine-related cancer"
DOI: 10.1530/erc-22-0168
Abstract: Prolactinomas have harmful effects on human health. Bromocriptine is the only commercially available drug in China, but about 25% of prolactinoma patients do not respond to it in clinic, its pathogenesis remains unknown. Thus, its… read more here.
Keywords: prolactinoma; estradiol; prl; expression ... See more keywords
Thyroid Autoimmunity and Subclinical Hypothyroidism in Prolactinoma: A Case Control Study
Sign Up to like & getrecommendations! Published in 2022 at "Indian Journal of Endocrinology and Metabolism"
DOI: 10.4103/ijem.ijem_425_21
Abstract: Background: This study was aimed at determining the frequency of thyroid autoimmunity and subclinical hypothyroidism in patients with hyperprolactinemia due to prolactinoma compared to well-matched healthy controls. Methods: This was a cross-sectional study wherein 78… read more here.
Keywords: prolactinoma; thyroid autoimmunity; subclinical hypothyroidism; study ... See more keywords
[Atypical presentation of a giant prolactinoma in a 15-year-old boy].
Sign Up to like & getrecommendations! Published in 2018 at "Archivos argentinos de pediatria"
DOI: 10.5546/aap.2018.e325
Abstract: Giant prolactinomas are rare pituitary adenomas characterized by their great local invasion. In this paper, we report a 15-year-old male with left retro-ocular pain and ipsilateral exophthalmos of 4 months of evolution, secondary to a… read more here.
Keywords: year old; prolactinoma; atypical presentation; giant prolactinoma ... See more keywords